Aynı zamanda, çok rekabetçi bir firmayız ve sektörün en iyisi olmak istiyoruz. Ayıca her zaman Avient’e en büyük yararı sağlayacak şekilde davranmak hepimizin yükümlülüğü olacaktır. Hepimizin en yüksek etik standartlara uygun şekilde çalışması önemlidir.

The concentrates offer long-term flame retardancy at low dosage and help fiber manufacturers meet key regulatory requirements by EN, DIN, UNI and others around the world.

This was achieved, in part, through Avient’s customer service, which offers commercial, logistics and technical support to stopper and cap producers on a global basis. If you’re considering a switch to TPEs, our expert team can consult on: • Part design • Application environment • Tooling and machine selection For additional information on the opportunities associated with TPEs, call us at +1.844.4AVIENT (1.844.428.4368) or visit avient.com. avient.com

At Avient Distribution, we help you achieve these goals with our comprehensive portfolio of leading suppliers, on-time delivery and a host of services focused on helping you succeed. At Avient Distribution, we’re prepared to help you: • Mitigate risk • Optimize design • Accelerate commercialization Contact us today to learn more about how we can help you overcome your toughest challenges.

Contact us at +1.844.4AVIENT or visit www.avient.com. Working with the Avient Design team on our VITALPOINT™ grip project was a big win for us. Avient had a good understanding our goals, turned revisions around fast, and helped us finish the project ahead of schedule,” said Zak Kurtshals, President, Hoyt Archery.

KEY BENEFITS • EPBP bottle-to-bottle recyclability accredited • Non-nylon based product • Compatible with rPET (recommended for >up to 100% rPET content) • No scavenging delay or deactivation • Excellent bottle clarity • Fit to use in monolayer as well as multi-layer bottle structures * European Platform for Bottle Packaging 1 https://eur-lex.europa.eu/legal-content/EN/ LSU/?

• Factors that could cause actual results to differ materially from those implied by these forward looking statements include but are not limited to:• Factors that could cause actual results to differ materially from those implied by these forward‐looking statements include, but are not limited to:  Our ability to achieve the strategic and other objectives relating to the Spartech acquisition, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The amount and timing of repurchases, if any, of PolyOne common shares and our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;g p y p g ;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;, , p y p y g , y p p ;  An inability to maintain appropriate relations with unions and employees; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. • The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward‐looking statements, whether as a result of new information, future events or otherwise. Strong past performance demonstrates that our strategy and execution are workinggy g • Megatrends align with our strengths • Innovation and services provide differentiation and competitive advantage • Strong and proven management team driving growth and performancegrowth and performance The New PolyOne: A Specialty Growth Company $2015 Target: $2.50 Adjusted EPS Page 16 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Senior management uses adjusted operating income, adjusted EPS, and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.

A wide range of opaque and translucent colors is available, as well as the option to work with us for any custom color requirements. Customized color solutions are available on request • Production under ISO 13485 / GMP quality system with change control management • Fingerprinting of raw materials and routine batch testing • Extractability evaluated in hexane, isopropanol, and water according to ISO 10993 part 18 REGULATORY SUPPORT • Raw materials are pre-tested to biologically- evaluated raw materials using ISO 10993-1 and USP chapters , Class VI • DMF/MAF documentation filed with the FDA for all standard colors APPLICATIONS MEVOPUR LQ formulations can be applied in demanding applications including: • Medical devices such as catheter tubing & connectors, syringe tips, and needleless connectors • Skin contact devices such as wearables or soft-touch surfaces of medical devices PRODUCT BULLETIN MEVOPUR™-LQ YELLOW (PMS1205C) Product Code FZ1M415005 MEVOPUR™-LQ TRANS YELLOW Product Code FZ1M415006 MEVOPUR™-LQ BLUE (PMS292C) Product Code FZ5M415008 MEVOPUR™-LQ TRANS BLUE Product Code FZ5M415009 MEVOPUR™-LQ RED (PMS198C) Product Code FZ3M415008 MEVOPUR™-LQ TRANS RED Product Code FZ3M415009 MEVOPUR™-LQ GREEN (PMS346C) Product Code FZ6M415008 MEVOPUR™-LQ TRANS GREEN Product Code FZ6M415009 MEVOPUR™-LQ VIOLET (PMS2655C) Product Code FZ4M415003 MEVOPUR™-LQ TRANS VIOLET Product Code FZ4M415004 CUSTOM-MADE Individual options Customized colors are also available to meet your needs, please contact us. Avient products have not been designed for nor are they promoted or intended for use in: (a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under US Pharmacopoeia (USP) or ISO standards; or (b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or (c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended.

They pass EN 50618 and IEC 60332-1 standards on the assembled cable (if the cable jacketing and insulation are both produced with ECCOH XL 8148 solutions).

Als ein in den USA ansässiges Unternehmen mit weltweiter Geschäftstätigkeit verpflichtet sich Avient zur Einhaltung der Verhaltensstandards, die im „US Sherman Act“, im „US Clayton Act“, im „US Robinson-Patman Act“ und im „US Federal Trade Commission Act“ niedergelegt sind, sowie zur Einhaltung lokaler Wettbewerbsgesetze aller Länder, in denen das Unternehmen tätig ist (zusammenfassend „Kartellgesetze“). Die Wichtigkeit der Einhaltung der US- Bundes- und -Bundesstaatsgesetze und ausländischen Kartellgesetze kann nicht genug betont werden. Die folgende Zusammenfassung der Kartellgesetze bezieht sich auf die US-Kartellgesetze.